1. Yuksel A, Bildik G, Senbabaoglu F, Akin N, Arvas M, Unal F, et al. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Hum Reprod 2015;30:2926-35.
2. Han M, Cheng H, Wang J, Yu Y, Wang F, Zhu R, et al. Abnormal aggregation of myeloid-derived suppressor cells in a mouse model of cyclophosphamide-induced premature ovarian failure. Gynecol Endocrinol 2019;35:985-90.
3. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2018;36:1994-2001.
5. Fujita T, Kozuka-Hata H, Ao-Kondo H, Kunieda T, Oyama M, Kubo T. Proteomic analysis of the royal jelly and characterization of the functions of its derivation glands in the honeybee. J Proteome Res 2013;12:404-11.
10. Khazaei F, Ghanbari E, Khazaei M. Protective effect of royal jelly against cyclophosphamide-induced thrombocytopenia and spleen and bone marrow damages in rats. Cell J 2020;22:302-9.
13. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-43.
14. Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med 2013;5:185ra62.
15. Lande Y, Fisch B, Tsur A, Farhi J, Prag-Rosenberg R, Ben-Haroush A, et al. Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro. Reprod Biomed Online 2017;34:104-14.
17. Ekiz Yilmaz T, Tasdemir M, Kaya M, Arican N, Ahishali B. The effects of magnesium sulfate on cyclophosphamide-induced ovarian damage: folliculogenesis. Acta Histochem 2020;122:151470.
19. Lopez SG, Luderer U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic Biol Med 2004;36:1366-77.
20. Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, et al. The natural carotenoid crocetin and the synthetic tellurium compound as101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers. Oxid Med Cell Longev 2017;2017:8928604.
21. Ghanbari E, Nejati V, Najafi G, Khazaei M, Babaei M. Study on the effect of royal jelly on reproductive parameters in streptozotocin-induced diabetic rats. Int J Fertil Steril 2015;9:113-20.
24. Valiollahpoor Amiri M, Deldar H, Ansari Pirsaraei Z. Impact of supplementary royal jelly on in vitro maturation of sheep oocytes: genes involved in apoptosis and embryonic development. Syst Biol Reprod Med 2016;62:31-8.
26. Eshtiyaghi M, Deldar H, Pirsaraei ZA, Shohreh B. Royal jelly may improve the metabolism of glucose and redox state of ovine oocytes matured in vitro and embryonic development following in vitro fertilization. Theriogenology 2016;86:2210-21.
27. Ghanbari E, Khazaei MR, Khazaei M, Nejati V. Royal jelly promotes ovarian follicles growth and increases steroid hormones in immature rats. Int J Fertil Steril 2018;11:263-9.
28. Elnagar SA. Royal jelly counteracts bucks’ “summer infertility”. Anim Reprod Sci 2010;121:174-80.
29. Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol 2017;217:129-40.